The Supreme Court’s recent decisions in Mayo Collaborative Services v. Prometheus Labs and Association for Molecular Pathology v. Myriad Genetics have drastically changed the outlook for applicants seeking biotechnology patents. Get an overview of the changes and what they mean for the biotechnology industry with the our study, Stopped at the Threshold: The Practical Impact of the Supreme Court's Mayo and Myriad Decisions on Biotechnology Patent Practices.
Written in conjunction with BIO and law firm Robins, Kaplan, Miller & Ciresi L.L.P, the study includes:
Notify me when updates are available (No standing order will be created).
Put me on standing order
Notify me when new releases are available (no standing order will be created)